Connexios Life Sciences

Bengaluru, India Founded: 2003 • Age: 23 yrs Minicorn
Develops targeted small molecule drugs for metabolic diseases.

About Connexios Life Sciences

Connexios Life Sciences was a Healthcare company based in Bengaluru (India) founded in 2003 by Suri Venkatachalam. It develops targeted small molecule drugs for metabolic diseases. It operates on a B2B model. Connexios Life Sciences has raised $34.25 million across 4 funding rounds from investors including Nadathur. The company has 1 employees. Connexios Life Sciences was last valued at $34.99 million in September 2016. Its chief executive, as recorded, is Suri Venkatachalam. Its Indian entity Connexios Life Sciences Private Limited reported revenue of β‚Ή7.17 Cr. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Drug Development and Metabolic Diseases.

Company details

Connexios Life Sciences develops targeted small molecule drugs for metabolic diseases through providing healthcare solutions, producing pharmaceutical products, drug development, and metabolic diseases. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Operational Areas
Key Metrics
  • Annual Revenue
    ₹7.17 Cr

    FY 2016

  • Net Loss
    -₹24.64 Cr

    FY 2016 · -344% margin

  • EBITDA
    -₹19.95 Cr

    FY 2016 · -278% margin

  • Total Equity Funding
    $34.25M (USD)

    in 4 rounds

  • Latest Funding Round
    $18.32M (USD), Series B

    Sep 2016

  • Investors
  • Employee Count
    1

Funding Insights of Connexios Life Sciences

Connexios Life Sciences has successfully raised a total of $34.25M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $18.32 million completed in September 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $34.25M
  • Total Rounds 4
  • Last Round Series B β€” $18.32M
  • Investors Count 1

All 4 funding rounds of Connexios Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2016$18.32MSeries B$34.99M–
–
Mar 2012$8.83MSeries A$21.02MNadathur
–
Aug 2009$7.1MSeries A$β€’β€’β€’β€’β€’Nadathur
–
Jun 2003Seed–Nadathur
–
Valuation history
DateValuationStage
Sep 2016$34.99Mβ€’β€’β€’β€’β€’β€’β€’β€’
Mar 2012$21.02Mβ€’β€’β€’β€’β€’β€’β€’β€’
Aug 2009$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Premium access

Full valuation and stage history of Connexios Life Sciences

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $34.99M (Sep 2016). 1 investors in total: 1 institutional.

Investors in Connexios Life Sciences

Connexios Life Sciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Nadathur.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Investments and philanthropy services offered by Nadathur Group.
2000nadathur.comBengaluru, India
Premium access

Investor details for Connexios Life Sciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Connexios Life Sciences Private Limited (Connexios Life Sciences)

Connexios Life Sciences Private Limited is the primary company behind Connexios Life Sciences. The board of Connexios Life Sciences Private Limited currently have 4 directors; the longest-serving is Sriram Nadathur, appointed in 2003. 7 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sriram Nadathur
DIN 00196449
Director25 Jul 200323 yrs 3 moConnexios Life Sciences Private Limited
Suri Venkatachalam
DIN 01095804
Managing Director25 Jul 200323 yrs 3 moConnexios Life Sciences Private Limited
Asha Diwakar
DIN 08279496
Company Secretary01 Jun 201610 yrs 5 moConnexios Life Sciences Private Limited
Nandan Laxman Sastry
DIN 03473182
Director05 Aug 201610 yrs 3 moConnexios Life Sciences Private Limited

People of Connexios Life Sciences

1 people are tracked at Connexios Life Sciences (1 in leadership); the tracked headcount is 1.

NameRoleGroup
Founder, CEOLeadership
Premium access

Complete people profiles for Connexios Life Sciences

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Connexios Life Sciences

Figures of Connexios Life Sciences Private Limited, the primary company behind Connexios Life Sciences, for FY 2016. Revenue was ₹7.17 Cr. Net loss was -₹24.64 Cr (-344% margin). EBITDA was -₹19.95 Cr (-278% margin).

  • ₹7.17 CrRevenue · FY 2016
  • -₹24.64 CrNet loss · -344% margin
  • -₹19.95 CrEBITDA · -278% margin
  • ₹7.43 CrPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Connexios Life Sciences Private Limited are on its company page.

Premium access

Detailed financial statements for Connexios Life Sciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Connexios Life Sciences

4 dated milestones of Connexios Life Sciences across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded Connexios Life Sciences is founded.
  2. Funding First funding round.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Series B, of $18.3M.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Connexios Life Sciences

Connexios Life Sciences was founded in 2003.

Connexios Life Sciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Suri Venkatachalam is the CEO of Connexios Life Sciences, as recorded in our data. They have also founded this company.

Connexios Life Sciences is a funded company, having raised a total of $34.25M across 4 funding rounds to date.

Connexios Life Sciences has 1 employees.

The primary company behind Connexios Life Sciences, Connexios Life Sciences Private Limited, reported revenue of β‚Ή7.17 Cr for FY 2016.

Connexios Life Sciences develops targeted small molecule drugs for metabolic diseases through providing healthcare solutions, producing pharmaceutical products, drug development, and metabolic diseases. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Connexios Life Sciences has 1 investor. Key investors include Nadathur.

The valuation of Connexios Life Sciences is $34.99M as of Sep 2016.

Connexios Life Sciences operates through Connexios Life Sciences Private Limited.

The legal entities of Connexios Life Sciences currently have 4 directors, including Sriram Nadathur, Nandan Laxman Sastry, Asha Diwakar and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available